DWJ 1543
Alternative Names: DWJ-1543Latest Information Update: 28 Jul 2023
At a glance
- Originator Daewoong Pharmaceutical
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Unspecified
Most Recent Events
- 24 Jul 2023 Daewoong Pharmaceutical plans a phase I trial in healthy volunteers in South Korea (PO) in August 2023 (NCT05954247)
- 24 Jul 2023 Preclinical trials in Unspecified in South Korea (unspecified route)
- 24 Jul 2023 Daewoong Pharmaceutical plans a phase I trial in healthy volunteers in South Korea (PO) in August 2023 (NCT05954338)